MEI Pharma http://investor.meipharma.com/ MEI Pharma to Present at Needham Healthcare Conference http://investor.meipharma.com/2017-03-28-MEI-Pharma-to-Present-at-Needham-Healthcare-Conference Live Webcast from New York on April 4th Tue, 28 Mar 2017 06:00:00 -0700 http://investor.meipharma.com/2017-03-28-MEI-Pharma-to-Present-at-Needham-Healthcare-Conference MEI Pharma to Present at Oppenheimer Healthcare Conference http://investor.meipharma.com/2017-03-14-MEI-Pharma-to-Present-at-Oppenheimer-Healthcare-Conference Live Webcast from New York on March 21st Tue, 14 Mar 2017 06:00:00 -0700 http://investor.meipharma.com/2017-03-14-MEI-Pharma-to-Present-at-Oppenheimer-Healthcare-Conference MEI Pharma Reports Second Quarter Fiscal Year 2017 Results http://investor.meipharma.com/2017-02-08-MEI-Pharma-Reports-Second-Quarter-Fiscal-Year-2017-Results Company Begins Calendar Year with $55 Million in Cash Wed, 08 Feb 2017 05:30:00 -0800 http://investor.meipharma.com/2017-02-08-MEI-Pharma-Reports-Second-Quarter-Fiscal-Year-2017-Results Helsinn Group and MEI Pharma Report Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia http://investor.meipharma.com/2016-12-05-Helsinn-Group-and-MEI-Pharma-Report-Prolongation-of-Survival-Results-from-Phase-2-Clinical-Study-of-Pracinostat-and-Azacitidine-in-Acute-Myeloid-Leukemia Phase 2 study results presented at American Society of Hematology Annual Meeting on Saturday, December 3, 2016 Mon, 05 Dec 2016 05:00:00 -0800 http://investor.meipharma.com/2016-12-05-Helsinn-Group-and-MEI-Pharma-Report-Prolongation-of-Survival-Results-from-Phase-2-Clinical-Study-of-Pracinostat-and-Azacitidine-in-Acute-Myeloid-Leukemia MEI Pharma to Host Annual Meeting of Stockholders http://investor.meipharma.com/2016-11-17-MEI-Pharma-to-Host-Annual-Meeting-of-Stockholders Live Webcast from San Diego on December 1st Thu, 17 Nov 2016 06:00:00 -0800 http://investor.meipharma.com/2016-11-17-MEI-Pharma-to-Host-Annual-Meeting-of-Stockholders